Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Revive Therapeutics reports preclinical data for REV-003

May 15, 2014

Early clinical and preclinical data presented for DS-5565

May 15, 2014

Lysosomal Therapeutics receives funding for neurodegenerative disease research

May 14, 2014

Inovio acquires rights to preclinical therapies for Alzheimer's and MS

May 14, 2014

FDA clears transfer of orphan drug designation for intrathecal resiniferatoxin to Sorrento

May 14, 2014

Janssen submits sNDAs to FDA for Invega Sustenna

May 14, 2014

Roche discloses novel Abeta production inhibitors

May 14, 2014

Jubilant Biosys and Orion form collaborative pain management program

May 14, 2014

Shin Poong's neuroprotective compound shows promising preclinical results

May 14, 2014

Santhera's phase III study of idebenone for DMD meets primary endpoint

May 13, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...